Physician profile
Luis E Manyari
NPI 1144297243
$1,807.08
in general payments reported to CMS, 2019-2025
18 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $540 · 2020: $307 · 2021: $317 · 2022: $143 · 2023: $95.25 · 2024: $273 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $432.43 | 2021-2024 | |
| Amgen INC. | $418.10 | 2023-2025 | Repatha, Repatha, Otezla |
| Pfizer INC. | $124.99 | 2020 | |
| Janssen Biotech, INC. | $115.80 | 2019-2020 | |
| Amarin Pharma, INC. | $112.11 | 2020 | |
| Medtronic USA, INC. | $95.87 | 2019 | |
| Theratechnologies INC. | $78.76 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.29 | 2019-2021 | |
| Mylan Specialty L.P. | $65.13 | 2019-2020 | |
| Gilead Sciences, INC. | $48.23 | 2019-2021 | |
| Glaxosmithkline, LLC. | $41.14 | 2019 | |
| Napo Pharmaceuticals INC | $40.38 | 2019-2022 | |
| Philips North America LLC | $40.06 | 2019 | |
| Vyera Pharmaceuticals, LLC | $31.55 | 2019 | |
| Merck Sharp & Dohme LLC | $26.24 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $21.63 | 2021 | |
| Allergan, INC. | $19.23 | 2020 | |
| Novartis Pharmaceuticals Corporation | $19.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Manyari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.